XML 45 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block] The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:
Year ended December 31,
202020192018
Product lineRevenue% of RevenueRevenue% of RevenueRevenue% of Revenue
Infusion Consumables$473,740 37 %$477,611 37 %$483,039 35 %
Infusion Systems359,691 28 %328,282 26 %355,484 25 %
IV Solutions388,971 31 %414,971 33 %507,985 36 %
Critical Care48,602 4 %45,344 4 %53,532 4 %
Total Revenues$1,271,004 100 %$1,266,208 100 %$1,400,040 100 %
    
    We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.    
    
    The following table represents our revenues disaggregated by geography (in thousands):
Year ended December 31,
Geography202020192018
Europe, the Middle East and Africa$132,763 $130,530 $134,363 
Other Foreign227,614 212,336 210,996 
Total Foreign360,377 342,866 345,359 
United States910,627 923,342 1,054,681 
Total Revenues$1,271,004 $1,266,208 $1,400,040 

Domestic sales accounted for 72%, 73% and 75% of total revenue in 2020, 2019 and 2018, respectively. International sales accounted for 28%, 27% and 25% of total revenue in 2020, 2019 and 2018, respectively.
Contract with Customer, Asset and Liability [Table Text Block] Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10, Accrued Liabilities and Other Long-term liabilities). The following table presents our changes in the contract balances for the years ended December 31, 2020 and 2019, (in thousands):
Contract Liabilities
Beginning balance, January 1, 2019$(4,282)
Equipment revenue recognized8,807 
Equipment revenue deferred due to implementation(8,794)
Software revenue recognized3,953 
Software revenue deferred due to implementation(4,539)
Ending balance, December 31, 2019$(4,855)
Equipment revenue recognized14,408 
Equipment revenue deferred due to implementation(14,341)
Software revenue recognized5,721 
Software revenue deferred due to implementation(7,363)
Ending balance, December 31, 2020$(6,430)